News articles about athenahealth (NASDAQ:ATHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. athenahealth earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news articles about the health services provider an impact score of 47.6436788774098 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the news articles that may have impacted Accern’s scoring:
- Wright Medical (WMGI) Poised on Acquisitions Amid Forex Woes – Nasdaq (nasdaq.com)
- Here’s Why You Should Invest in Baxter International Now – Nasdaq (nasdaq.com)
- Global Electronic Health Records Markets and Technologies 2018-2022: Key Vendors are Agfa-Gevaert N.V., Amazon.com, Analogic, athenahealth and Beckman Coulter (markets.financialcontent.com)
- Healthicity Partners with athenahealth’s ‘More Disruption Please’ Program to Simplify Healthcare Compliance and Auditing (prweb.com)
- DocSpera Partners with athenahealth’s ‘More Disruption Please’ Program to Streamline Pre- and Post-Operative Coordination and Improve Decision Support (prnewswire.com)
Several research firms have recently weighed in on ATHN. Bank of America initiated coverage on shares of athenahealth in a research report on Tuesday, February 27th. They issued a “neutral” rating and a $147.00 target price on the stock. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a research report on Saturday, February 17th. Piper Jaffray Companies reissued a “buy” rating and issued a $160.00 target price on shares of athenahealth in a research report on Friday, February 16th. Royal Bank of Canada set a $141.00 target price on shares of athenahealth and gave the stock a “hold” rating in a research report on Thursday, February 15th. Finally, SunTrust Banks boosted their price objective on shares of athenahealth to $180.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. Three analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have assigned a buy rating to the stock. athenahealth currently has a consensus rating of “Hold” and an average price target of $144.35.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.48. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company had revenue of $329.20 million during the quarter, compared to the consensus estimate of $319.64 million. During the same quarter last year, the firm earned $0.62 earnings per share. The company’s revenue was up 14.2% on a year-over-year basis. research analysts predict that athenahealth will post 2.69 EPS for the current year.
In other athenahealth news, CEO Jonathan Bush sold 25,000 shares of athenahealth stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $145.00, for a total value of $3,625,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Bradford Kyle Armbrester sold 2,235 shares of the business’s stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $138.70, for a total value of $309,994.50. Following the sale, the senior vice president now owns 10,146 shares in the company, valued at $1,407,250.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 108,705 shares of company stock worth $14,891,199. Company insiders own 3.20% of the company’s stock.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.